Hector Garcia

Hector Garcia

Interventional cardiologist / Cardiologist
MedStar Washington Hospital Center - Washington, United States of America

Latest contributions

Intracoronary imaging guidance for PCI

22 May 2025 – From EuroPCR 2025

This session highlights the value of intracoronary imaging guidance for PCI, showcasing optical coherence tomography in complex ACS lesions, long-term outcomes from imaging-guided PCI trials, AI-enhanced quantification, and comparative analyses of intravascular lithotripsy versus rotational atherectomy.

Intracoronary imaging guidance for PCI

Which device for which patient: DES, BRS or DCB?

22 May 2025 – From EuroPCR 2025

This session provides comprehensive guidance on selecting the appropriate device—DES, BRS, or DCB—for individual patients and lesions. It examines patient and lesion characteristics, strengths and limitations of each device type, and regional considerations, illustrated by case presentations demonstrating practical device choice and resolution.

Which device for which patient: DES, BRS or DCB?

How should I treat this vulnerable plaque?

21 May 2025 – From EuroPCR 2025

Learn to identify and manage vulnerable plaque using intracoronary imaging. This session covers detection techniques, clinical implications, current evidence for treatment, and case-based insights to improve patient outcomes through targeted intervention.

How should I treat this vulnerable plaque?

Imaging-based strategies for complication management in STEMI

21 May 2025 – From EuroPCR 2025

Discover imaging-based strategies to manage complications during STEMI interventions. This session discusses diagnostic clues such as spasm, stuck devices, and slow flow, and illustrates complex scenarios including extreme stent challenges and application of CTO techniques to STEMI cases for optimized outcomes.

Imaging-based strategies for complication management in STEMI

The future is now: QFR and RMS to optimise coronary artery disease patient management

20 May 2025 – From EuroPCR 2025

See how next-generation technologies are reshaping coronary artery disease treatment in this EuroPCR 2025 session. Learn how QFR is being used to plan PCI and evaluate results, and discover new insights into RMS technology—offering a potential leap beyond traditional drug-eluting stents. From practical case experience to...

The future is now: QFR and RMS to optimise coronary artery disease patient management

Coronary artery disease: more imaging, less imagination

18 May 2023 – From EuroPCR 2023

In these slides, explore associations between angiography-based FFR and OCT-detected luminal obstruction, prognostic impact of ischaemia vs. plaque vulnerability, CT's mortality foresight, and much more.

Coronary artery disease: more imaging, less imagination

Artificial intelligence: current applications in coronary image analysis in its potential in treatment planning

18 May 2023 – From EuroPCR 2023

What should cardiologists be aware of regarding artificial intelligence? How will artificial intelligence impact interventional cardiology? If you share these questions, absolutely watch this presentation.

Artificial intelligence: current applications in coronary image analysis in its potential in treatment planning

DCB and scaffolds

16 May 2023 – From EuroPCR 2023

Watch this session to learn about 4 cases, including a patient who underwent successful PTCA with BRS on LAD using the PSP technique, and discuss the best option to consider when choosing between DEB and stents in tricky situations and individual patients.

DCB and scaffolds

New tools and techniques in coronary lesion assessment

17 May 2022 – From EuroPCR 2022

Consult this session to learn about new tools and techniques in coronary lesion assessment, such as: the ability of near infra-red spectroscopy to identify vulnerable patients and plaques, the iFR value impact on left internal mammary artery graft patency, the FFR-guided stent optimisation in focal and diffuse coronary...

New tools and techniques in coronary lesion assessment

PROSPECT II, COMBINE (OCT–FFR) and PROSPECT ABSORB: After revascularization of culprit lesions, assessment of coronary plaque size and composition matter!

17 Oct 2020

PROSPECT II, COMBINE (OCT–FFR) and PROSPECT ABSORB trials were presented at TCT Connect 2020. Hector Garcia-Garcia provides a summary of the key messages.

Author

Hector Garcia

PCRonline @ TCT Connect 2020

25 Sep 2020

View reviews and take-home messages from a selection of major Late-breaking Clinical Trials in Interventional Cardiology released at the 2020 online edition of TCT Connect. Check out the list here!

Exploring evidence and experience with magnesium scaffold Magmaris

23 May 2019 – From EuroPCR 2019

Consult this session on magnesium scaffold Magmaris to learn more about the available data on its clinical use and to review interesting intravascular imaging data after Magmaris implantation.

Exploring evidence and experience with magnesium scaffold Magmaris

Magnesium scaffolds: Magmaris technology and clinical evaluation

21 May 2019 – From EuroPCR 2019

Consult this session on Magmaris' technology to learn more about the benefits, implantation technique and optimal indications, thanks to a selection of clinical cases and studies, and discover the next generation magnesium scaffold developments.

Magnesium scaffolds: Magmaris technology and clinical evaluation